title: New drugs. Azilsartan medoxomil, belimumab, and lurasidone hydrochloride.
authors.affiliation: Philadelphia College of Pharmacy, University of the Sciences, Philadelphia, USA.
authors.forename: Daniel A
authors.initials: DA
authors.lastname: Hussar
authors.forename: Anokhi
authors.initials: A
authors.lastname: Shah
mesh_terms: D047228:Angiotensin II Type 1 Receptor Blockers / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D000911:Antibodies, Monoclonal / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D014150:Antipsychotic Agents / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use; D001562:Benzimidazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D054833:Isoindoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D008180:Lupus Erythematosus, Systemic / Q000188:drug therapy; D000069056:Lurasidone Hydrochloride; D010069:Oxadiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*; D012559:Schizophrenia / Q000188:drug therapy; D013844:Thiazoles / Q000009:adverse effects / Q000494:pharmacology / Q000627:therapeutic use*
chemical_list: D047228:Angiotensin II Type 1 Receptor Blockers; D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D014150:Antipsychotic Agents; D001562:Benzimidazoles; D054833:Isoindoles; D010069:Oxadiazoles; D013844:Thiazoles; C511911:belimumab; C557413:azilsartan medoxomil; D000069056:Lurasidone Hydrochloride